Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 99

    NCLAT stays eviction of over Rs 9000 crore debt-ridden Sterling Biotech from its premises

    NCLAT stays eviction of over Rs 9000 crore debt-ridden Sterling Biotech from its premises

    Farhat Nasim5 Aug 2019 9:10 AM IST
    The appellate tribunal observed that although Sterling Biotech, which is presently going through liquidation, is not the owner of the premises it...
    Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

    Families say OxyContin maker Purdue Pharma must be held accountable for its role in opioid epidemic

    Medical Dialogues Bureau5 Aug 2019 9:00 AM IST
    The parents and their supporters rallied outside a Boston courthouse Friday as a judge heard arguments in Massachusetts' lawsuit against Purdue...
    GSK gets European nod for pre-filled pen, syringe Nucala for patients with severe eosinophilic asthma

    GSK gets European nod for pre-filled pen, syringe Nucala for patients with severe eosinophilic asthma

    Medical Dialogues Bureau4 Aug 2019 9:50 AM IST
    UK: GlaxoSmithKline (GSK) recently announced that the European Commission has granted marketing authorization for two new methods of administering...
    Daiichi Sankyo Turalio wins USFDA nod for treatment of rare joint tumour

    Daiichi Sankyo Turalio wins USFDA nod for treatment of rare joint tumour

    Medical Dialogues Bureau4 Aug 2019 9:45 AM IST
    Turalio is the first approved therapy in the United States for TGCT, the primary treatment of which has so far been surgery, the agency said.U.S: The...
    E-cigarette giant Juul Labs campaign donations favour Democrats: Report

    E-cigarette giant Juul Labs campaign donations favour Democrats: Report

    Medical Dialogues Bureau4 Aug 2019 9:15 AM IST
    Juul and cigarette maker Altria — which controls 35 per cent of the vaping company — have backed a Senate bill that raises the age nationally. The...
    Hikma Pharma signs agreement with Civica Rx to produce 14 sterile injectable medications

    Hikma Pharma signs agreement with Civica Rx to produce 14 sterile injectable medications

    Medical Dialogues Bureau4 Aug 2019 9:10 AM IST
    Under the agreement, Hikma will produce 14 essential sterile injectable medications for Civica as a private label distributor, using Hikma's...
    Protest planned outside court during Purdue Pharma hearing

    Protest planned outside court during Purdue Pharma hearing

    Medical Dialogues Bureau4 Aug 2019 9:00 AM IST
    Purdue Pharma will argue in Suffolk Superior Court that Democratic state Attorney General Maura Healey's lawsuit distorts facts, makes oversimplified...
    Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

    Zydus Cadila wins USFDA nod for Minocycline Hydrochloride ER tablets to treat acne

    Medical Dialogues Bureau3 Aug 2019 9:45 AM IST
    Minocycline hydrochloride extended-release tablets are indicated to treat only inflammatory lesions of non-modular moderate to severe acne vulgaris in...
    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Pfizer, GSK completes transaction to form new consumer healthcare JV

    Medical Dialogues Bureau3 Aug 2019 9:40 AM IST
    The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and...
    Unichem Labs gets 4 USFDA observations for Goa formulation facility

    Unichem Labs gets 4 USFDA observations for Goa formulation facility

    Farhat Nasim3 Aug 2019 9:39 AM IST
    At the end of an inspection, the facility received four observations, with no repeat observations and are mostly procedural in nature, Unichem Labs...
    Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments

    Novartis, Gilead costly cancer therapies Yescarta, Kymriah losing patients to experimental treatments

    Medical Dialogues Bureau3 Aug 2019 9:15 AM IST
    Both Gilead's Yescarta and Novartis's Kymriah - which are part of a class of therapies known in the medical field as "CAR-T" - were approved in 2017....
    Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

    Philippines weighs re-use of Sanofi controversial dengue vaccine Dengvaxia

    Medical Dialogues Bureau3 Aug 2019 9:14 AM IST
    The Philippines stopped using Dengvaxia in late 2017 and ordered Sanofi to stop selling, distributing and marketing it after Sanofi warned the vaccine...
    PrevNext

    Popular Stories

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    What Makes Group Medical Insurance Cheaper than Individual Insurance

    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    Desi AI based healthtech startup NIRAMAI raises Rs 42.6 Crore in Series A Funding

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Top Pharmacy Courses That Rule the Industry

    Top Pharmacy Courses That Rule the Industry

    SMS Pharma updates against USFDA statement on Ranitidine

    SMS Pharma updates against USFDA statement on Ranitidine

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Paras Healthcare ties up with J K Hospital, plans Rs 50 crore investment for comprehensive services

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    Suven Life Sciences Q2 revenue up 39pc to Rs 280 crore

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok